This report presents a comprehensive overview, market shares, and growth opportunities of the Ranibizumab market by product type, application, key companies, and key regions.
New York, United States – June 22, 2020 /MarketersMedia/ —
Ranibizumab is a monoclonal antibody fragment obtained from the same parental murine antibody as bevacizumab. It is an anti-angiogenic drug that has been approved for the treatment of AMD patients.
Biomedicine has achieved rapid growth in the global pharmaceutical market due to its high pharmacological activity, strong specificity, and good therapeutic effect. In the biopharmaceutical market, the monoclonal antibody is the most subdivided category. With the development of biotechnology, the research on monoclonal antibodies will be further deepened, and the patients’ demand for monoclonal antibodies will also be further increased. Ranibizumab is mainly used for the treatment of age-related macular degeneration (AMD), a retinal disease that increases the incidence with age and causes a significant decrease in vision. Diabetic retinopathy and diabetic macular edema can also be treated with ranibizumab. Therefore, the deepening of global aging and the increasing incidence of chronic diseases such as diabetes will promote the expansion of demand for ranibizumab.
Get FREE Sample of Ranibizumab Market Report at:
https://www.globalmarketmonitor.com/request.php?type=3&rid=579033
The Major Players Profiled in This Report Include:
Genentech
Novartis
Indian pharmaceutical company Intas Pharmaceuticals has launched RAZUMAB™, a biosimilar of Lucentis® (Ranibizumab). The product is entirely manufactured in India, and the price of RAZUMAB™ is much cheaper than Lucentis®, which will allow the drug to be used in a wider patient population.
The Type and Application Analysis:
On the basis of type, this report displays the sales volume, revenue (Million USD), product price, market share and growth rate of each type, primarily split into:
Single-use prefilled syringe
Single-use glass vial
On the basis of application, this report displays the sales volume, revenue (Million USD), product price, market share and growth rate of each application/end users, primarily divided into:
AMD
Diabetic Retinopathy (DR)
Diabetic Macular Edema (DME)
mCNV
RVO
To Identify the Key Trends in the Industry, Click on the Link Below:
https://www.globalmarketmonitor.com/reports/579033-ranibizumab-market-report.html
The Asia-Pacific region will become one of the most important markets for ranibizumab. This is due to the rapid development of the local economy and medical technology, especially in India and China. In China, the existing AMD patients are conservatively estimated to have exceeded 11 million, of which the number of nAMD patients exceeds 1.7 million. And ranibizumab is a medical insurance drug in China. With the aging of the population, the number of AMD patients will further increase, so China is still one of the most promising markets for ranibizumab.
Ranibizumab Report Table of Content:
Chapter 1 Report Overview
Chapter 2 Market Trends and Competitive Landscape
Chapter 3 Segmentation of Ranibizumab Market by Types
Chapter 4 Segmentation of Ranibizumab Market by End-Users
Chapter 5 Market Analysis by Major Regions
Chapter 6 Product Commodity of Ranibizumab Market in Major Countries
Chapter 7 North America Ranibizumab Landscape Analysis
Chapter 8 Europe Ranibizumab Landscape Analysis
Chapter 9 Asia Pacific Ranibizumab Landscape Analysis
Chapter 10 Latin America, Middle East & Africa Ranibizumab Landscape Analysis
Chapter 11 Major Players Profile
11.1 Genentech
11.1.1 Genentech Company Profile and Recent Development
11.1.2 Market Performance
11.1.3 Product and Service Introduction
11.2 Novartis
11.2.1 Novartis Profile and Recent Development
11.2.2 Market Performance
11.2.3 Product and Service Introduction
Chapter 12 Data Source and Research Methodology
The List of Tables and Figures
Inquire More or Share Questions if Any Before the Purchase on Ranibizumab Report:
https://www.globalmarketmonitor.com/request.php?type=3&rid=579033
Key Questions Answered in This Report:
Which Trends Are Causing These Developments?
Who Are the Global Key Players in Ranibizumab Market? What’ s Their Company Profile, Their Product Information, Contact Information?
What Was Global Market Status of Ranibizumab Market? What Was Capacity, Production Value, Cost, and PROFIT of Ranibizumab Market?
What’s Market Analysis of Ranibizumab Market by Taking Applications and Types in Consideration?
What Will Be the Estimation of Cost and Profit? What Will Be Market Share, Supply, and Consumption? What About Import and Export?
What Is Ranibizumab Market Chain Analysis by Upstream Raw Materials and Downstream Industry?
What Is Economic Impact on Ranibizumab Market? What are Global Macroeconomic Environment Analysis Results? What Are Global Macroeconomic Environment Development Trends?
Contact Info:
Name: Quella
Email: Send Email
Organization: Market Monitor
Address: One Pierrepont Plaza, 14th Floor, 300 Cadman Plaza W,Brooklyn, NY 11201, USA
Phone: + 1 (347) 467 7721
Website: https://www.globalmarketmonitor.com/
Source: MarketersMedia
Release ID: 88964843
